1. Home
  2. MAIA vs STI Comparison

MAIA vs STI Comparison

Compare MAIA & STI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • STI
  • Stock Information
  • Founded
  • MAIA 2018
  • STI 2014
  • Country
  • MAIA United States
  • STI United States
  • Employees
  • MAIA N/A
  • STI N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • STI
  • Sector
  • MAIA Health Care
  • STI
  • Exchange
  • MAIA Nasdaq
  • STI NYSE
  • Market Cap
  • MAIA 46.7M
  • STI 51.2M
  • IPO Year
  • MAIA 2022
  • STI N/A
  • Fundamental
  • Price
  • MAIA $2.15
  • STI $0.10
  • Analyst Decision
  • MAIA
  • STI
  • Analyst Count
  • MAIA 0
  • STI 0
  • Target Price
  • MAIA N/A
  • STI N/A
  • AVG Volume (30 Days)
  • MAIA 79.7K
  • STI 3.7M
  • Earning Date
  • MAIA 05-13-2025
  • STI 06-06-2025
  • Dividend Yield
  • MAIA N/A
  • STI N/A
  • EPS Growth
  • MAIA N/A
  • STI N/A
  • EPS
  • MAIA N/A
  • STI N/A
  • Revenue
  • MAIA N/A
  • STI N/A
  • Revenue This Year
  • MAIA N/A
  • STI N/A
  • Revenue Next Year
  • MAIA N/A
  • STI N/A
  • P/E Ratio
  • MAIA N/A
  • STI N/A
  • Revenue Growth
  • MAIA N/A
  • STI N/A
  • 52 Week Low
  • MAIA $1.40
  • STI $0.08
  • 52 Week High
  • MAIA $5.99
  • STI $3.25
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 70.43
  • STI 40.12
  • Support Level
  • MAIA $1.51
  • STI $0.08
  • Resistance Level
  • MAIA $1.61
  • STI $0.11
  • Average True Range (ATR)
  • MAIA 0.12
  • STI 0.02
  • MACD
  • MAIA 0.06
  • STI 0.01
  • Stochastic Oscillator
  • MAIA 90.91
  • STI 27.83

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About STI SOLIDION TECHNOLOGY INC

Solidion Technology Inc is engaged in researching, developing and manufacturing battery materials and components, as well as the development and production of next-generation batteries for energy storage systems and electric vehicles for ground, air, and sea transportation. It is recognized as a global IP leader in both the high-capacity anode and the high-energy solid-state battery.

Share on Social Networks: